{"id":"W4379281877","doi":"10.1200/jco.2023.41.16_suppl.e24078","title":"Incidence of second primary malignancies (SPMs) in patients with multiple myeloma (MM) receiving anti-CD38 monoclonal antibodies (mAbs): A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Pomalidomide; Multiple myeloma; Oncology; Confidence interval; Surgery; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0116602,0.002037008,0.01466662,0.005511668,0.0003788469,0.002229448,0.001670822,0.001925427,0.002559858],"category_scores_gemma":[0.02613154,0.001386299,0.03377622,0.006847869,0.0005582501,0.001320299,0.001218009,0.001517068,0.0002289494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002172597,"about_ca_system_score_gemma":0.00207777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005966977,"about_ca_topic_score_gemma":0.01239581,"domain_scores_codex":[0.9912351,0.004415451,0.002357349,0.0009493417,0.0008051781,0.0002375603],"domain_scores_gemma":[0.9808072,0.01365348,0.003987974,0.00039404,0.0009365467,0.00022069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00256497,0.00002663331,0.007671035,0.3088153,0.6701084,0.0001379407,0.00007068856,0.0005395101,0.0001959961,0.0001158053,0.0005837933,0.009169869],"study_design_scores_gemma":[0.0007582504,0.0002726387,0.00622344,0.01835567,0.972397,0.0001531069,0.00004603829,0.0002060791,0.0001114072,0.0001592819,0.001296607,0.00002045619],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01064511,0.9870362,0.0004784873,0.0002498279,0.0001268137,0.0002691247,0.0008923145,0.00002071965,0.00028149],"genre_scores_gemma":[0.3584556,0.6355162,0.002287903,0.0008411263,0.0002310099,0.001167643,0.001139859,0.00002815955,0.0003324155],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9853334,"threshold_uncertainty_score":0.06166577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2236129353640777,"score_gpt":0.4796070211839271,"score_spread":0.2559940858198494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}